CTL019 (Novartis)

CTL019
(Novartis)

Cancer r/r ALL Oncology
Approved (US)

CTL019

This is a partner's product, where Oxford Biomedica provide process development and bioprocessing. For more information on Novartis products visit the Novartis website.